Jinling Huang Selected Research

ling-gui-zhu-gan decoction

1/2020	Ling-Gui-Zhu-Gan Decoction Protects H9c2 Cells against H2O2-Induced Oxidative Injury via Regulation of the Nrf2/Keap1/HO-1 Signaling Pathway.
10/2018	Effect of Ling-Gui-Zhu-Gan decoction major components on the plasma protein binding of metoprolol using UPLC analysis coupled with ultrafiltration.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jinling Huang Research Topics

Disease

4	Uterine Cervical Neoplasms (Cancer of the Cervix) 12/2019 - 06/2013
4	Neoplasms (Cancer) 07/2017 - 09/2011
3	Inflammation (Inflammations) 01/2021 - 01/2016
2	Coronary Disease (Coronary Heart Disease) 12/2021 - 10/2018
2	Autoimmune Diseases (Autoimmune Disease) 01/2021 - 01/2021
2	Heart Failure 01/2020 - 06/2013
2	Hypoxia (Hypoxemia) 06/2019 - 06/2013
2	Ovarian Neoplasms (Ovarian Cancer) 06/2019 - 01/2019
1	Dysbiosis 01/2021
1	Rheumatoid Arthritis 01/2021
1	Colitis 01/2021
1	Ulcerative Colitis 01/2021
1	Dermatomyositis (Dermatopolymyositis) 01/2021
1	Turcot syndrome 01/2020
1	Diabetic Nephropathies (Diabetic Nephropathy) 01/2020
1	Stroke (Strokes) 01/2020
1	Ischemia 01/2020
1	Brain Ischemia (Cerebral Ischemia) 01/2020
1	Neoplasm Metastasis (Metastasis) 12/2019
1	Psoriasis (Pustulosis Palmaris et Plantaris) 01/2019
1	Disease Resistance 01/2019
1	Cardiac Arrhythmias (Arrythmia) 10/2018
1	Dehydration (Water Stress) 01/2018
1	Carcinogenesis 07/2017
1	Autoimmune Hepatitis 01/2017
1	Infections 01/2016
1	Mycoses (Diseases, Fungus) 01/2016
1	Uterine Cervical Dysplasia 06/2013
1	Hepatocellular Carcinoma (Hepatoma) 09/2012
1	Necrosis 09/2011
1	Body Weight (Weight, Body) 04/2007

Drug/Important Bio-Agent (IBA)

3	Interleukin-17 (Interleukin 17)IBA 01/2019 - 01/2016
3	Biological ProductsIBA 07/2017 - 06/2013
3	Pharmaceutical PreparationsIBA 01/2017 - 09/2011
2	ling-gui-zhu-gan decoctionIBA 01/2020 - 10/2018
2	Long Noncoding RNAIBA 12/2019 - 07/2017
2	Proteins (Proteins, Gene)FDA Link 06/2013 - 06/2013
2	1-phenyl-3,3-dimethyltriazene (PDT)IBA 09/2012 - 09/2011
1	Air Pollutants (Pollutants, Air)IBA 12/2021
1	InterleukinsIBA 01/2021
1	MicroRNAs (MicroRNA)IBA 01/2021
1	Biomarkers (Surrogate Marker)IBA 01/2021
1	Antimicrobial PeptidesIBA 01/2021
1	Interleukin-22 (IL-22)IBA 01/2021
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2020
1	astragaloside AIBA 01/2020
1	Glucose (Dextrose)FDA LinkGeneric 01/2020
1	ligustilideIBA 01/2020
1	Neuroprotective AgentsIBA 01/2020
1	Oxygen (Dioxygen)IBA 01/2020
1	Small Interfering RNA (siRNA)IBA 06/2019
1	Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA 06/2019
1	TOR Serine-Threonine KinasesIBA 06/2019
1	Imiquimod (Aldara)FDA LinkGeneric 01/2019
1	paeonolIBA 01/2019
1	Interleukin-23 (Interleukin 23)IBA 01/2019
1	Interleukin-17 ReceptorsIBA 01/2019
1	UbiquitinIBA 01/2019
1	Metoprolol (Toprol-XL)FDA LinkGeneric 10/2018
1	HemerythrinIBA 01/2018
1	CytokinesIBA 01/2016
1	TM 1IBA 01/2016
1	hydroxycamptothecinumIBA 10/2015
1	homocamptothecinIBA 10/2015
1	Antineoplastic Agents (Antineoplastics)IBA 10/2015
1	Type I DNA Topoisomerases (Topoisomerase I)IBA 10/2015
1	ImmunosorbentsIBA 06/2013
1	Messenger RNA (mRNA)IBA 06/2013
1	HexokinaseIBA 06/2013
1	NF-kappa B (NF-kB)IBA 06/2013
1	cobaltous chloride (cobalt(II)chloride)IBA 06/2013
1	Facilitative Glucose Transport Proteins (Glucose Transporter)IBA 06/2013
1	EnzymesIBA 06/2013
1	phthalocyanineIBA 09/2012
1	MetalsIBA 09/2012
1	P-2 (P 2)IBA 04/2007
1	zinc(II) phthalocyanine trisulfonic acidIBA 04/2007

Therapy/Procedure

2	Photochemotherapy (Photodynamic Therapy) 09/2012 - 09/2011
2	Lasers (Laser) 09/2011 - 04/2007
1	Chinese Traditional Medicine (Traditional Chinese Medicine) 10/2018
1	Therapeutics 07/2017
1	Ligation 06/2013